Becton, Dickinson (BDX) | Stock Overview & Key Data
Becton, Dickinson Performance Comparison
Stock Range
Today's Range
Low: $188.95
High: $191.68
on October 2, 2025
52 Week Range
Low: $163.33
High: $251.99
on May 6, 2025
on February 3, 2025
All-Time High: $287.32 on July 24, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$54.9B
EPS
5.45
P/E Ratio (TTM)
33.59
Forward P/E
11.64
P/B Ratio
2.06
PEG Ratio
1.76
Div. Yield
1.80%
ROE
6.18%
Beta
0.297
Debt to Equity
75.93
Financial Highlights
Profitability
Gross Margin
47.81%
Operating Margin
17.81%
Profit Margin
7.41%
Returns and Earnings
Return on Assets (TTM)
3.96%
Return on Equity (TTM)
6.18%
EBITDA
$5.4B
Net Income (TTM)
$1.6B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$73.97
Quarterly Revenue Growth (YoY)
10.40%
Quarterly Earnings Growth (YoY)
17.90%
Dividend Information
Last 12-Month Dividend
$3.03
Current Dividend Yield
1.80%
3-Year Average Dividend Yield
0.40%
3-Year Average Annual Dividend
$3.16
3-Year Total Dividends
$9.48
Ex-Dividend Date
March 10, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Becton, Dickinson BDX | 54.91B Large-cap | 6.10% | 1.83% | 8.08% | -15.38% | -15.40% | -19.57% | -13.95% | -17.24% |
| Intuitive Surgical ISRG | 157.45B Large-cap | 1.12% | -5.56% | -18.05% | -12.63% | -15.46% | -8.08% | 134.79% | 80.04% |
| Alcon ALC | 45.84B Large-cap | 2.55% | -4.04% | -15.89% | -18.88% | -9.99% | -22.78% | 28.31% | 21.85% |
| ResMed RMD | 40.08B Large-cap | 3.49% | 2.08% | 8.11% | 24.05% | 21.08% | 18.23% | 24.38% | 57.07% |
| West Pharmaceutical WST | 19.61B Large-cap | 7.34% | 12.07% | 23.48% | 23.32% | -16.82% | -7.87% | 9.34% | -8.42% |
| Hologic HOLX | 14.94B Large-cap | 3.22% | 1.95% | 4.00% | 12.14% | -5.34% | -15.37% | 6.51% | -2.13% |
Ownership & Short Interest
Insider Ownership
0.57%
Institutional Ownership
92.25%
Shares Short
4M
Short Ratio
2.41
Short % of Shares Outstanding
1.50%
Average 10-Day Volume
1M
Average 90-Day Volume
2M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BDX's 52-week high and low?
- In the last 52 weeks, Becton, Dickinson reached a high of $251.99 (on February 3, 2025) and a low of $163.33 (on May 6, 2025).
- What is the market cap and P/E ratio for BDX?
- Curious about Becton, Dickinson's size and valuation? Its market capitalization stands at 54.91B. When it comes to valuation, the P/E ratio (trailing twelve months) is 33.59, and the forward P/E (looking ahead) is 11.64.
- Does BDX pay dividends? If so, what's the yield?
- Yes, Becton, Dickinson is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.80%, and the company has paid an average of $3.16 per share annually over the past 3 years.
- Who are Becton, Dickinson's main competitors or similar companies to consider before investing?
When looking at Becton, Dickinson, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG157.45B Healthcare Medical Instruments & Supplies -8.08% 134.79% Alcon
ALC45.84B Healthcare Medical Instruments & Supplies -22.78% 28.31% ResMed
RMD40.08B Healthcare Medical Instruments & Supplies 18.23% 24.38% West Pharmaceutical
WST19.61B Healthcare Medical Instruments & Supplies -7.87% 9.34% Hologic
HOLX14.94B Healthcare Medical Instruments & Supplies -15.37% 6.51% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Becton, Dickinson and Company? (e.g., ROE, Debt/Equity)
- To get a sense of Becton, Dickinson's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.18%, the Debt to Equity ratio from the most recent quarter is 75.93, and its Gross Profit Margin stands at 47.81%.
- What is the recent revenue and earnings growth for BDX?
- Looking at Becton, Dickinson's growth, its revenue over the trailing twelve months (TTM) was $21B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.40%, and quarterly earnings saw a YoY growth of 17.90%.
- How much of BDX stock is held by insiders and institutions?
- Wondering who owns Becton, Dickinson stock? Company insiders (like executives and directors) hold about 0.57% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 92.25%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.